Back to Sites

Malawi CRS

Site Number

12001

Address

University of North Carolina Lilongwe
Kamuzu Central Hospital/Tidziwe Centre
Mzimba Road
Lilongwe,
Malawi

IMPAACT Members at this Site

Maggie Malola CAB Member

Bright Manuel Mtambasha CAB Member

Steven M. Mphonda Community Educator

Mina Hosseinipour CRS Coordinator

Peter (Thokozani) Makuhunga CRS Coordinator

Lameck Chinula CRS Leader

Francis E. Martinson CRS Leader

Susan Pedersen RN, BSN CTU Coordinator

Joseph Eron CTU Principal Investigator

Mina Hosseinipour CTU Principal Investigator

David Wohl CTU Principal Investigator

Dara Potter DAIDS PO

George Dickie Data Management Staff

Nkhafwire E. Mkandawire Data Manager

Portia Kamthunzi Investigator

Mark Maluwa Investigator

Godwin Chipoka Medical Officer

Cornelius Mukuzunga Medical Officer

Friday Saidi Medical Officer

Wilberforce Mhango Pharmacist

Victor Palichina Pharmacy Technician

Blessings Chikoko QA/QC Coordinator

Clement Tembo QA/QC Coordinator

Studies at this Site

P1060: NNRTI-Based vs. PI-Based ART in Infants Exposed/Not Exposed to NVP for PMTCT

DAIDS Number

10166

Research Area

Treatment

Study Status

Concluded

P1068S: Parasitemia And Clinical Malaria In Children On Protease-Inhibitor-Based Therapy

DAIDS Number

10661

Research Area

Other

Study Status

Concluded

P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY

DAIDS Number

10765

Research Area

Other

Study Status

Concluded

P1084s: Maternal Infant TDF Toxicity Safety

DAIDS Number

10790

Research Area

Therapeutics

Study Status

Closed to Follow Up

P1092: Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children

DAIDS Number

11689

Research Area

Therapeutics

Study Status

Participants Off Study and Primary Analysis Completed

1077BF: PROMISE 1077BF

DAIDS Number

10777

Research Area

Prevention

Study Status

Participants Off Study and Primary Analysis Completed

P1104s: Longitudinal Developmental and Neuropsychological Assessments of HIV-Infected Participants of P1060 and HIV-Uninfected Controls

DAIDS Number

11878

Research Area

Brain and Mental Health

Study Status

Participants Off Study and Primary Analysis Completed

P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study

DAIDS Number

11954

Research Area

Cure and Immunotherapy

Study Status

Enrolling

IMPAACT 2001: A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-infected and HIV-1-uninfected Pregnant and Postpartum Women with Latent Tuberculosis Infection

DAIDS Number

12026

Research Area

Tuberculosis

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2008: Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 with Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants

DAIDS Number

20735

Research Area

Cure and Immunotherapy

Study Status

Participants Off Study and Primary Analysis Completed